| |  | | | | By Lung-I Cheng Adobe Kymriah, the first cell and gene therapy, was approved five years ago. It will take work to get the next wave of these therapies to patients. Read More | | By Sarah Owermohle APStock The guidance from the White House’s Office of Science and Technology Policy effectively ushers in a sea change in the publishing industry. Read More | | By Michael B. Farber and Anand Shah Jeff Chiu/AP The Supreme Court's decision in West Virginia v. EPA could limit the FDA's efforts to regulate tobacco and e-cigarettes. Read More | | Sponsor content by STAT Reports The race for longevity: How scientists are seeking to extend healthy lives In the early 1990s, a biologist’s findings showed that aging, age-related illnesses, and even death were processes directed by genetic programs, raising the tantalizing prospect that they might one day be at least partly controlled by drugs or therapies. Our latest report examines the science behind the longevity industry, exploring what we know about the biology of aging and the various types of interventions scientists are studying to help slow or reverse its corrosive effects. Download now. | | By Usha Lee McFarling Vanessa Leroy for STAT Mass General Brigham is undertaking a campaign to address the systemic racism that has led to poorer outcomes for patients of color. Read More | | By Tara Bannow Adobe Fed up with the costly, onerous process of recertification, doctors are increaasingly turning to an alternative board. Read More | |
No comments